Patents by Inventor Mohammed Arif Iftekhar

Mohammed Arif Iftekhar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulation of inflammatory response following endovascular treatment
    Patent number: 11717392
    Abstract: A method of treating an aortic aneurysm of a patient with an endovascular graft system and mitigating post implant syndrome associated therewith comprises placing at least one prosthesis across an aneurysmal space. The prosthesis comprises a double-walled filling structure and a stent-graft. The stent graft is radially expanded at a first pressure and the filing structure is filled with a first filing agent to contact a thrombus in the aortic aneurysmal space. After the first filling agent is removed, the filling structure is filled with a second filling agent to contact the thrombus. Next the stent-graft is expanded at a second pressure causing the filing structure to place an effective amount of pressure on the thrombus and substantially mitigating the effects of post implant syndrome associated with the prosthesis.
    Type: Grant
    Filed: April 22, 2019
    Date of Patent: August 8, 2023
    Assignee: Endologix LLC
    Inventors: Mohammed Arif Iftekhar, Peter Costandi, Carlos Ortega, Chris Williams, Craig Welk
  • MODULATION OF INFLAMMATORY RESPONSE FOLLOWING ENDOVASCULAR TREATMENT
    Publication number: 20210093440
    Abstract: A method of treating an aortic aneurysm of a patient with an endovascular graft system and mitigating post implant syndrome associated therewith comprises placing at least one prosthesis across an aneurysmal space. The prosthesis comprises a double-walled filling structure and a stent-graft. The stent graft is radially expanded at a first pressure and the filing structure is filled with a first filing agent to contact a thrombus in the aortic aneurysmal space. After the first filling agent is removed, the filling structure is filled with a second filling agent to contact the thrombus. Next the stent-graft is expanded at a second pressure causing the filing structure to place an effective amount of pressure on the thrombus and substantially mitigating the effects of post implant syndrome associated with the prosthesis.
    Type: Application
    Filed: April 22, 2019
    Publication date: April 1, 2021
    Inventors: Mohammed Arif Iftekhar, Peter Costandi, Carlos Ortega, Chris Williams, Craig Welk